Yesterday, we announced that the Phase 3 inMIND trial met its primary endpoint.
We’ve announced positive topline results from the Phase 3 inMIND trial in patients with relapsed or refractory follicular lymphoma (FL). Learn more. #News https://bit.ly/46NgHWo
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study https://lnkd.in/e9mxHeNB
Classic, ALK-DUSp22-, TP63- primary cutaneous anaplastic large cell lymphoma https://lnkd.in/dprhVkWp
MSAT Scientist I Personalized Medicine I Ai/ML| hiPSCs stem cells | Analytics & QC | cGMP | Cell & Gene Therapy | CAR-T ♋I CAR-T | ImmunoTherapy | Gene editing CRISPR🧬✂️ #CAR-T🔬🦠🩸🫁🫀|
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma https://lnkd.in/gjd3ZHwj
🔬 EBER+ Stain: Observe an EBER+ stain in a Hodgkin Reed Sternberg cell in a case of classic Hodgkin lymphoma. EBER expression is seen in ~50% of cases, providing valuable insight for differentiating some CD30+ lymphoma. #hemepath #lymphoma #PathTwitter
💫ONCOnews💫 🌟 Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study 👉 Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphoma 🔗 https://buff.ly/3Q0aMGr #OncEd #ONCOnews #OncoAlert
Secondary CNS involvement of ALK-negative anaplastic large cell lymphoma https://lnkd.in/eye8geUQ
✅Accelerated approval to lisocabtagene maraleucel for adults with relapsed or refractory follicular lymphoma. The recommended lisocabtagene maraleucel dose is 90 to 110 × 106 CAR-positive viable T cells with a 1:1 ratio of CD4 & CD8 components. READ➡️https://lnkd.in/eAFyJJ5x
Metabolic Regulation of Lymphoma Development: #AACRFellows Tak W. Mak will address this topic in a keynote lecture at the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia). Learn more: https://bit.ly/3IOXuIW #AACRlymph24
Multiple Intussusceptions due to Lymphoma From "CT of Lymphoma: Involvement of the GI Tract - Part 2" View the full lecture here: https://lnkd.in/ganUC63h
Small Bowel Lymphoma: CT Findings https://lnkd.in/einGKwgD
